$2.56
arrow_drop_down7.58%Key Stats | |
---|---|
Open | $2.82 |
Prev. Close | $2.79 |
EPS | -6.16 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $25.74M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.82 | 2.83 |
52 Week Range | 2.16 | 10.50 |
Ratios | |
---|---|
EPS | -6.16 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
SAb Biotherapeutics Rebrands as SAB BIO
SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SAB Biotherapeutics Provides SAB-142 Trial Update